$AGTX
Agentix Corp

2024 Q3 Form 10-K Financial Statement

#000147793224005401 Filed on August 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q1 2024
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $175.3K
YoY Change -75.37%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $744.8K
YoY Change -45.7%
Operating Profit -$744.8K
YoY Change -45.7%
Interest Expense $21.03K
YoY Change -1126.05%
% of Operating Profit
Other Income/Expense, Net -$159.7K
YoY Change -7891.9%
Pretax Income -$585.2K
YoY Change -57.41%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$585.2K
YoY Change -57.41%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 10.07M shares 40.07M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q1 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $6.535K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $106.4K
YoY Change -59.31%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $106.4K
Total Long-Term Assets $0.00
Total Assets $106.4K
YoY Change -59.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $961.7K
YoY Change -60.77%
Accrued Expenses $23.82K
YoY Change 161.42%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.667M
YoY Change 6.22%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.667M
Total Long-Term Liabilities $0.00
Total Liabilities $2.667M
YoY Change 6.22%
SHAREHOLDERS EQUITY
Retained Earnings -$5.954M
YoY Change 10.9%
Common Stock $40.07K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.560M
YoY Change
Total Liabilities & Shareholders Equity $106.4K
YoY Change -59.31%

Cashflow Statement

Concept 2024 Q3 2024 Q1 2024
OPERATING ACTIVITIES
Net Income -$585.2K
YoY Change -57.41%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$110.4K
YoY Change 24.72%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $93.00K
YoY Change -7.0%
NET CHANGE
Cash From Operating Activities -$110.4K
Cash From Investing Activities $0.00
Cash From Financing Activities $93.00K
Net Change In Cash -$5.834K
YoY Change -150.91%
FREE CASH FLOW
Cash From Operating Activities -$110.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Assets
Assets
106372 usd
CY2023Q1 us-gaap Assets
Assets
261392 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
961661 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
249023 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
261392 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23815 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2666594 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 usd
CY2024Q1 us-gaap Liabilities
Liabilities
2666594 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
40067 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3288296 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12360 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
99837 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1057215 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9110 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2510555 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
40067 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5954480 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5369326 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-2560222 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2249163 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
106372 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
261392 usd
CY2023Q1 agtx Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
1394230 usd
CY2023Q1 agtx Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
50000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2510555 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3025796 usd
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001603345
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40066951 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40066951 shares
CY2023Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
357102 shares
CY2024 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024 dei Entity File Number
EntityFileNumber
000-55383
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity Registrant Name
EntityRegistrantName
AGENTIX CORP.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2876282
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
32932 Pacific Coast Highway
CY2024 dei Entity Address Address Line2
EntityAddressAddressLine2
#14-254
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Dana Point
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92629
CY2024 dei City Area Code
CityAreaCode
321
CY2024 dei Local Phone Number
LocalPhoneNumber
299-2014
CY2024 dei Security12g Title
Security12gTitle
Common Stock, $.001 par value
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Public Float
EntityPublicFloat
2190563 usd
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10066931 shares
CY2024 dei Auditor Name
AuditorName
Fruci & Associates II, PLLC
CY2024 dei Auditor Firm
AuditorFirmId
5525
CY2024 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6535 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12369 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
106372 usd
CY2024Q1 agtx Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
1538118 usd
CY2024Q1 agtx Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
143000 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40066951 shares
CY2024Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
357102 shares
CY2024Q1 agtx Common Stock To Be Issued
CommonStockToBeIssued
53535 usd
CY2023Q1 agtx Common Stock To Be Issued
CommonStockToBeIssued
53535 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
765 usd
CY2024 agtx Professional Fees Expense
ProfessionalFeesExpense
222999 usd
CY2023 agtx Professional Fees Expense
ProfessionalFeesExpense
520238 usd
CY2024 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
175268 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
711506 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
346543 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
140012 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
744810 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
1371756 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-744810 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-1371756 usd
CY2024 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
17929 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
406 usd
CY2024 us-gaap Interest Expense
InterestExpense
21034 usd
CY2023 us-gaap Interest Expense
InterestExpense
1643 usd
CY2024 us-gaap Interest Income Other
InterestIncomeOther
248 usd
CY2023 us-gaap Interest Income Other
InterestIncomeOther
0 usd
CY2024 us-gaap Other Income
OtherIncome
198371 usd
CY2023 us-gaap Other Income
OtherIncome
0 usd
CY2024 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-159656 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2049 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-585154 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1373805 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-585154 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1373805 usd
CY2024 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11595 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
765 usd
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-573559 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1373040 usd
CY2024 agtx Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
CY2023 agtx Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.04
CY2024 agtx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
40066951 shares
CY2023 agtx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
39232019 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1076998 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
30600 usd
CY2023 agtx Common Stock Issued To Consultants Amount
CommonStockIssuedToConsultantsAmount
45900 usd
CY2023 agtx Common Stock Granted For Services
CommonStockGrantedForServices
42375 usd
CY2023 agtx Stock Issued During Period Value Issued For Software
StockIssuedDuringPeriodValueIssuedForSoftware
32000 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
765 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1373805 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2249163 usd
CY2024 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11595 usd
CY2024 agtx Former Ceo Consulting Fees Determined To Not Be Owed
FormerCeoConsultingFeesDeterminedToNotBeOwed
262500 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-585154 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-2560222 usd
CY2024 us-gaap Profit Loss
ProfitLoss
-585154 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-1373805 usd
CY2024 agtx Amortization Of Stock Issued For Software
AmortizationOfStockIssuedForSoftware
31576 usd
CY2023 agtx Amortization Of Stock Issued For Software
AmortizationOfStockIssuedForSoftware
19954 usd
CY2024 agtx Consulting Fees Not Owed And Reflected As Additional Paid In Capital
ConsultingFeesNotOwedAndReflectedAsAdditionalPaidInCapital
262500 usd
CY2023 agtx Consulting Fees Not Owed And Reflected As Additional Paid In Capital
ConsultingFeesNotOwedAndReflectedAsAdditionalPaidInCapital
0 usd
CY2024 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
CY2023 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
118875 usd
CY2024 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
117609 usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-221143 usd
CY2024 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
63040 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
1367578 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-110429 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-88541 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2024 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
163000 usd
CY2023 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
50000 usd
CY2024 us-gaap Repayments Of Debt
RepaymentsOfDebt
70000 usd
CY2023 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
93000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
100000 usd
CY2024 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11595 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
765 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5834 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12224 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12369 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
145 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6535 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12369 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
3223 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024 agtx Issuance Of Stock For Software Subscription
IssuanceOfStockForSoftwareSubscription
0 usd
CY2023 agtx Issuance Of Stock For Software Subscription
IssuanceOfStockForSoftwareSubscription
32000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6535 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period.  Among other things, management estimates include the assumptions made for accruals and potential liabilities and realization of deferred tax assets.  These estimates generally involve complex issues and require judgments, involve analysis of historical information and the prediction of future trends, and are subject to change from period to period. Actual amounts could differ significantly from these estimates.</p>
CY2023Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
50000 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40066951 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40066951 shares
CY2023 agtx Common Stock Issued During Period Shares New Issues
CommonStockIssuedDuringPeriodSharesNewIssues
200000 shares
CY2023Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.25
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000 usd
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1706000 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1132000 usd
CY2024Q1 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
1706000 usd
CY2023Q1 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
1132000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024 agtx Effective Income Tax Rate Reconciliation At Nol Carry Forwards Blended Rate
EffectiveIncomeTaxRateReconciliationAtNolCarryForwardsBlendedRate
0.21 pure

Files In Submission

Name View Source Status
0001477932-24-005401-index-headers.html Edgar Link pending
0001477932-24-005401-index.html Edgar Link pending
0001477932-24-005401.txt Edgar Link pending
0001477932-24-005401-xbrl.zip Edgar Link pending
agtx-20240331.xsd Edgar Link pending
agtx_10k.htm Edgar Link pending
agtx_10kimg2.jpg Edgar Link pending
agtx_ex311.htm Edgar Link pending
agtx_ex312.htm Edgar Link pending
agtx_ex321.htm Edgar Link pending
agtx_ex971.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
agtx-20240331_cal.xml Edgar Link unprocessable
agtx-20240331_def.xml Edgar Link unprocessable
agtx-20240331_lab.xml Edgar Link unprocessable
agtx-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
agtx_10k_htm.xml Edgar Link completed